Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Italian consensus statement on paediatric HIV infection.

Giaquinto C, Penazzato M, Rosso R, Bernardi S, Rampon O, Nasta P, Ammassari A, Antinori A, Badolato R, Castelli Gattinara G, d'Arminio Monforte A, De Martino M, De Rossi A, Di Gregorio P, Esposito S, Fatuzzo F, Fiore S, Franco A, Gabiano C, Galli L, Genovese O, Giacomet V, Giannattasio A, Gotta C, Guarino A, Martino A, Mazzotta F, Principi N, Regazzi MB, Rossi P, Russo R, Saitta M, Salvini F, Trotta S, Viganò A, Zuccotti G, Carosi G; Italian Paediatric HIV Infection Working Group.

Infection. 2010 Aug;38(4):301-19. doi: 10.1007/s15010-010-0020-5. Epub 2010 Jun 1.

PMID:
20514509
2.

Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week Off.

Regazzi MB, Russo D, Iacona I, Sacchi S, Visani G, Lazzarino M, Avvisati G, Pelicci PG, Dastoli G, Grandi C, Spreafico S, Grattoni R, Galieni P, Rupoli S, Maiolo AM, Guerra E, Liberati AM.

Clin Drug Investig. 1998;16(1):25-33.

PMID:
18370515
3.

A new sensitive enzyme-linked immunosorbent assay (ELISA) for Alemtuzumab determination: development, validation and application.

Montagna M, Avanzini MA, Visai L, Locatelli F, Montillo M, Morra E, Regazzi MB.

Int J Immunopathol Pharmacol. 2007 Apr-Jun;20(2):363-71.

PMID:
17624249
4.

Pharmacokinetic behavior of rituximab: a study of different schedules of administration for heterogeneous clinical settings.

Regazzi MB, Iacona I, Avanzini MA, Arcaini L, Merlini G, Perfetti V, Zaja F, Montagna M, Morra E, Lazzarino M.

Ther Drug Monit. 2005 Dec;27(6):785-92.

PMID:
16306856
5.

New strategies in immunosuppression.

Regazzi MB, Alessiani M, Rinaldi M.

Transplant Proc. 2005 Jul-Aug;37(6):2675-8. Review.

PMID:
16182781
6.

Limited sampling strategy for the estimation of systemic exposure to the protease inhibitor nelfinavir.

Regazzi MB, Tinelli C, Villani P, Cusato M, Zucchi P, De Silvestri A, Briganti E, Roda R, Sacchelli L, Gatti F, Foglie PD, Nardini G, Mori F, Castelli P, Testa L, Maserati R.

Ther Drug Monit. 2005 Oct;27(5):571-5.

PMID:
16175128
7.

Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections.

Villani P, Regazzi MB, Marubbi F, Viale P, Pagani L, Cristini F, Cadeo B, Carosi G, Bergomi R.

Antimicrob Agents Chemother. 2002 Mar;46(3):936-7. No abstract available.

8.

A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.

Lazzarino M, Arcaini L, Bernasconi P, Alessandrino EP, Gargantini L, Cairoli R, Orlandi E, Astori C, Brusamolino E, Pagnucco G, Colombo AA, Calatroni S, Iacona I, Regazzi MB, Morra E.

Br J Haematol. 2002 Jan;116(1):229-35.

PMID:
11841421
9.

Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile.

Regazzi MB, Seminari E, Villani P, Carriero PL, Montagna M, Marubbi F, Maserati R.

J Chemother. 2001 Oct;13(5):569-74.

PMID:
11760223
10.

Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV.

Bruno R, Regazzi MB, Ciappina V, Villani P, Sacchi P, Montagna M, Panebianco R, Filice G.

Clin Pharmacokinet. 2001;40(9):695-700.

PMID:
11605717
11.
12.

Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy.

Villani P, Viale P, Signorini L, Cadeo B, Marchetti F, Villani A, Fiocchi C, Regazzi MB, Carosi G.

Antimicrob Agents Chemother. 2001 Jul;45(7):2160-2.

13.

Pharmacokinetics of tacrolimus during the early phase after heart transplantation.

Molinaro M, Regazzi MB, Pasquino S, Rinaldi M, Iacona I, Campana C, Viganò M.

Transplant Proc. 2001 May;33(3):2386-9. No abstract available.

PMID:
11377570
14.

Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring, of heart transplant recipients.

Regazzi MB, Molinaro M, Tinelli C, D'Eril GM, Goggi C, Campana C, Fiorito V, Moratti R, Viganò M.

Ther Drug Monit. 2000 Dec;22(6):712-5.

PMID:
11128239
15.

Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors.

Seminari E, Maggiolo F, Villani P, Suter F, Pan A, Regazzi MB, Paolucci S, Baldanti F, Tinelli C, Maserati R.

J Acquir Immune Defic Syndr. 1999 Dec 15;22(5):453-60. Erratum in: J Acquir Immune Defic Syndr 2000 Mar 1;23(3):278.

PMID:
10961606
16.

Influenza immunization and indinavir pharmacokinetics.

Maserati R, Villani P, Barasolo G, Mongiovetti M, Regazzi MB.

Scand J Infect Dis. 2000;32(4):449-50. No abstract available.

PMID:
10959668
17.

Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study.

Iacona I, Lazzarino M, Avanzini MA, Rupolo M, Arcaini L, Astori C, Lunghi F, Orlandi E, Morra E, Zagonel V, Regazzi MB.

Ther Drug Monit. 2000 Jun;22(3):295-301.

PMID:
10850396
18.

Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients.

Regazzi MB, Villani P, Maserati R, Seminari E, Pan A, LoCaputo F, Gambarana E, Fiocchi C.

J Antimicrob Chemother. 2000 Mar;45(3):343-7.

PMID:
10702554
19.

Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients.

Villani P, Regazzi MB, Castelli F, Viale P, Torti C, Seminari E, Maserati R.

Br J Clin Pharmacol. 1999 Nov;48(5):712-5.

20.

High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma.

Villani P, Pregnolato M, Banfo S, Rettani M, Burroni D, Seminari E, Maserati R, Regazzi MB.

Ther Drug Monit. 1999 Jun;21(3):346-50.

PMID:
10365651
21.

High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease.

Maserati R, Villani P, Seminari E, Pan A, Lo Caputo S, Regazzi MB.

AIDS. 1999 May 7;13(7):870-1. No abstract available.

PMID:
10357395
22.

Epirubicin in a breast cancer patient with Gilbert's syndrome: apparent lack of major pharmacokinetic alterations.

Riggi M, Poggesi I, Regazzi MB, Grasso S, Fittipaldo A, Seematter RJ.

Ann Oncol. 1999 Mar;10(3):360-1. No abstract available.

23.

[The stability of all-trans retinoic acid in "retinoid solutions" of "Di Bella's Cure"].

Iacona I, Bartoli AN, Rettani M, Daneri A, Alcini Terzoni P, Bascapè V, Regazzi MB.

Boll Chim Farm. 1999 Jan;138(1):1-6. Italian.

PMID:
10326308
24.

Pharmacokinetic variability and strategy for therapeutic drug monitoring of saquinavir (SQV) in HIV-1 infected individuals.

Regazzi MB, Villani P, Maserati R, Cocchi L, Giacchino R, Burroni D, Rettani M.

Br J Clin Pharmacol. 1999 Apr;47(4):379-82.

25.

The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischaemia.

Mazzone A, Cusa C, Bucci L, Vezzoli M, Ghio S, Buggia I, Regazzi MB, Fossati G, Mazzucchelli I, Gritti D.

Eur J Clin Invest. 1999 Jan;29(1):1-5.

PMID:
10092981
26.

Clinical pharmacokinetics of tacrolimus in heart transplant recipients.

Regazzi MB, Rinaldi M, Molinaro M, Pellegrini C, Calvi M, Arbustini E, Bellotti E, Bascapè V, Martinelli L, Viganò M.

Ther Drug Monit. 1999 Feb;21(1):2-7.

PMID:
10051048
27.

Neoral increases bioavailability versus oral Sandimmune after porcine small bowel transplantation.

Rossi G, Reggiani P, Regazzi MB, Gatti S, Ceccherelli F, Prato P, Galmarini D, Fassati LR.

Transplant Proc. 1998 Sep;30(6):2654-6. No abstract available.

PMID:
9745535
28.

Co-trimoxazole administered for Pneumocystis carinii pneumonia prophylaxis does not interfere with saquinavir pharmacokinetics.

Maserati R, Villani P, Cocchi L, Regazzi MB.

AIDS. 1998 May 7;12(7):815-6. No abstract available.

PMID:
9619815
29.

Clinical pharmacokinetics of tretinoin.

Regazzi MB, Iacona I, Gervasutti C, Lazzarino M, Toma S.

Clin Pharmacokinet. 1997 May;32(5):382-402. Review.

PMID:
9160172
30.

Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation.

Regazzi MB, Alessiani M, Reggiani P, Gatti S, Spada M, Iacona I, Rossi G, Tzakis A.

Transplant Proc. 1997 May;29(3):1857-60. No abstract available.

PMID:
9142302
31.

Tacrolimus and mycophenolate mofetil in pig small bowel transplantation: different protocols and their outcome.

Spada M, Alessiani M, Ferrari P, Iacona I, Abbiati F, Viezzoli A, Regazzi MB, Bellinzona G, Dionigi P, Zonta A.

Transplant Proc. 1997 May;29(3):1819-20. No abstract available.

PMID:
9142286
32.

Mycophenolic acid in combination with FK 506: a pharmacokinetic study in piglets after small-bowel transplantation.

Iacona I, Alessiani M, Spada M, Regazzi MB.

Transplant Proc. 1997 Feb-Mar;29(1-2):701-2. No abstract available.

PMID:
9123489
33.

Clinical relevance of all-trans retinoic acid pharmacokinetics and its modulation in acute promyelocytic leukemia.

Lazzarino M, Regazzi MB, Corso A.

Leuk Lymphoma. 1996 Nov;23(5-6):539-43. Review.

PMID:
9031084
34.

Endogenous beta-endorphins in hypertension: correlation with 24-hour ambulatory blood pressure.

Guasti L, Cattaneo R, Daneri A, Bianchi L, Gaudio G, Regazzi MB, Grandi AM, Bertolini A, Restelli E, Venco A.

J Am Coll Cardiol. 1996 Nov 1;28(5):1243-8. Erratum in: J Am Coll Cardiol 1997 Feb;29(2):474.

35.

Response of aleukemic granulocytic sarcoma to all-trans-retinoic acid plus interferon alfa-2a.

Toma S, Palumbo R, Giordano D, Arcuri T, Regazzi MB.

J Natl Cancer Inst. 1996 Oct 16;88(20):1494-5. No abstract available.

PMID:
8841027
36.

Pharmacokinetic profile of mycophenolic acid in piglets after small bowel transplantation.

Iacona I, Regazzi MB, Spada M, Villani P, Molinaro M, Alessiani M.

Transplant Proc. 1996 Oct;28(5):2525-6. No abstract available.

PMID:
8907934
37.

Modulation of all-trans-retinoic acid administered on intermittent schedule by alpha-interferon 2a in a patient with AIDS-related Kaposi's sarcoma.

Toma S, Iacona I, Palumbo R, Moresco L, Raffo P, Regazzi MB.

AIDS. 1996 Aug;10(9):1049-50. No abstract available.

PMID:
8853745
38.

Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo).

Buggia I, Zecca M, Alessandrino EP, Locatelli F, Rosti G, Bosi A, Pession A, Rotoli B, Majolino I, Dallorso A, Regazzi MB.

Anticancer Res. 1996 Jul-Aug;16(4A):2083-8.

PMID:
8712747
39.

[Role of clinical pharmacology in the monitoring of therapy of HIV-infected subjects].

Villani P, Cocchi L, Giacchino R, Seminari E, Regazzi MB, Maserati R.

Clin Ter. 1996 Jun;147(6):279-93. Review. Italian.

PMID:
8925637
40.

Clinical and pharmacokinetic evaluation of a new lipid-based delivery system of amphotericin B in AIDS patients.

Villani P, Regazzi MB, Maserati R, Viale P, Alberici F, Giacchino R.

Arzneimittelforschung. 1996 Apr;46(4):445-9.

PMID:
8740098
41.

Interaction between FK 506 and diltiazem in an animal model.

Regazzi MB, Iacona I, Alessiani M, Spada M, Vaccarisi S, Villani P, Molinaro M.

Transplant Proc. 1996 Apr;28(2):1017-8. No abstract available.

PMID:
8623215
42.

Clinically significant drug interactions with cyclosporin. An update.

Campana C, Regazzi MB, Buggia I, Molinaro M.

Clin Pharmacokinet. 1996 Feb;30(2):141-79. Review.

PMID:
8906896
43.

Pharmacokinetics of hydroxyurea in patients infected with human immunodeficiency virus type I.

Villani P, Maserati R, Regazzi MB, Giacchino R, Lori F.

J Clin Pharmacol. 1996 Feb;36(2):117-21.

PMID:
8852387
44.

Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-alpha therapy.

Lazzarino M, Corso A, Regazzi MB, Iacona I, Bernasconi C.

Br J Haematol. 1995 Aug;90(4):928-30.

PMID:
7669674
45.

Efficacy and pharmacokinetics of simvastatin in heart transplant recipients.

Campana C, Iacona I, Regazzi MB, Gavazzi A, Perani G, Raddato V, Montemartini C, Viganò M.

Ann Pharmacother. 1995 Mar;29(3):235-9.

PMID:
7606066
46.

Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.

Regazzi MB, Iacona I, Campana C, Gavazzi A, Viganò M, Perani G.

Transplant Proc. 1994 Oct;26(5):2644-5. No abstract available.

PMID:
7940825
47.

Busulfan.

Buggia I, Locatelli F, Regazzi MB, Zecca M.

Ann Pharmacother. 1994 Sep;28(9):1055-62. Review.

PMID:
7803883
48.

Evaluation of two buflomedil tablet formulations in patients with atherosclerotic disease.

Molinaro M, Regazzi MB, Raffaghello S, Buggia I, Iacona I, Graziani P, Specchia G, Melzi D'eril G.

J Clin Pharm Ther. 1994 Apr;19(2):111-5.

PMID:
8071390
49.

High-performance liquid chromatography determination of pravastatin in plasma.

Iacona I, Regazzi MB, Buggia I, Villani P, Fiorito V, Molinaro M, Guarnone E.

Ther Drug Monit. 1994 Apr;16(2):191-5.

PMID:
8009569
50.

Once daily felodipine in preventing ergonovine-induced myocardial ischaemia in Prinzmetal's variant angina.

Chimienti M, Negroni MS, Pusineri E, Regazzi MB, Inglese L, Klersy C, De Ambroggi L.

Eur Heart J. 1994 Mar;15(3):389-93.

PMID:
8013514

Supplemental Content

Loading ...
Support Center